Walleye Trading’s Guardant Health GH Stock Holding History

Walleye Trading’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,600	Closed	-$69K	–	4283
2024 Q4	$48.9K	Buy	+1,600	New	+$45K	﹤0.01%	3798
2024 Q1	–	Sell	-7,699	Closed	-$208K	–	4981
2023 Q4	$208K	Buy	7,699 +184	+2%	+$4.83K	﹤0.01%	3750
2023 Q3	$223K	Buy	+7,515	New	+$264K	﹤0.01%	3538
2023 Q1	–	Sell	-5,115	Closed	-$146K	–	5035
2022 Q4	$139K	Sell	5,115 -16,044	-76%	-$734K	﹤0.01%	3810
2022 Q3	$1.14M	Buy	+21,159	New	+$1.09M	﹤0.01%	2155
2022 Q2	–	Sell	-17,459	Closed	-$865K	–	5325
2022 Q1	$1.16M	Buy	+17,459	New	+$1.19M	﹤0.01%	2100
2021 Q4	–	Sell	-65	Closed	-$6.72K	–	5532
2021 Q3	$8K	Sell	65 -3,741	-98%	-$444K	﹤0.01%	5023
2021 Q2	$473K	Sell	3,806 -14,026	-79%	-$1.89M	﹤0.01%	2977
2021 Q1	$2.72M	Buy	17,832 +4,998	+39%	+$755K	0.01%	1096
2020 Q4	$1.65M	Buy	+12,834	New	+$1.48M	0.01%	1542
2020 Q3	–	Sell	-4,997	Closed	-$457K	–	4306
2020 Q2	$405K	Buy	+4,997	New	+$403K	﹤0.01%	2441

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Walleye Trading's GH Position: Q1 2025 in Review

Walleye Trading sold out of Guardant Health (GH) in Q1 2025, closing a stake of 1,600 shares — an estimated $69K sold.

Walleye Trading first reported a position in GH in Q2 2020 and held it in 11 quarters. The position peaked at $2.72M in Q1 2021. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

Walleye Trading reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
Walleye Trading sold 1,600 Guardant Health shares in Q1 2025, an estimated $69K.
Walleye Trading first reported a position in Guardant Health in Q2 2020 and held it in 11 quarters.
Walleye Trading's Guardant Health position peaked at $2.72M in Q1 2021.
342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.